logo
Select company
Select metric
-67.62%Return on Equity
VS
Market
16
Sector
41
Industry
52
History
54
$ 8.15Close
$ 1.9 - $ 14.3 52-Week Range
Ticker Information

Ticker

CRVO

Company Name

CERVOMED INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERVOMED INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRVO - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 33.44M$ -22.61M-67.62%
3/31/2025$ 34.63M$ -18.67M-53.91%
12/31/2024$ 39.2M$ -16.29M-41.56%
9/30/2024$ 45.64M$ -11.95M-26.18%
6/30/2024$ 49.98M$ -5.04M-10.09%
3/31/2024$ 5.34M$ -4.84M-90.69%
12/31/2023$ 7.38M$ -2.17M-29.44%
9/30/2023$ 9.57M$ -8.13M-84.93%
6/30/2023$ 14.23M$ -13.08M-91.92%
3/31/2023$ 16.28M$ -15.16M-93.11%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERVOMED INC's latest trailing twelve months (TTM) ROE stands at -55.09%.
  • Over the past 5 years, CERVOMED INC's average ROE has been -61.01%.
  • The median ROE for CERVOMED INC during this period was -64.88%
  • CERVOMED INC reached its highest ROE over the past 5 years at -10.09%.
  • The lowest ROE recorded by CERVOMED INC in the same timeframe -93.11%

CERVOMED INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
TCRX : TSCAN THERAPEUTICS INC -77.4%FATE : FATE THERAPEUTICS INC -65.63%CUE : CUE BIOPHARMA INC -214.19%SRZN : SURROZEN INC -73.51%OVID : OVID THERAPEUTICS INC -68.43%ARMP : ARMATA PHARMACEUTICALS INC -CBUS : CIBUS INC -381.75%VERU : VERU INC -213.17%PSTV : PLUS THERAPEUTICS INC -627.13%ORMP : ORAMED PHARMACEUTICALS INC -15.67%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for CERVOMED INC is calculated as follows: Net Inc. Cmn. [ $ -15.83M ] / Equity [ $ 28.72M ]
(=) ROE [ -55.09% ]

CRVO - Return on Equity, Last 5 years

-93.11%

Minimum

Mar 31, 2023

-10.09%

Maximum

Jun 30, 2024

-61.01%

Average

-64.88%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%